MEG3 is known to modulate the activity of TGF-β gene expression by forming RNA–DNA triplex structures, thereby binding distal regulatory elements, leading to its transcriptional repression in breast cancer cells [23]. This evidence concerns the gene MEG3 and breast carcinoma.